Current Issue

ADA releases updated Standards of Care for 2025

The American Diabetes Association (ADA) has added new recommendations on screening for type 1 diabetes, referring for dental care, and addressing female sexual dysfunction, among other topics.

Trial supports insulin as first-line treatment for gestational diabetes

Metformin plus glyburide as needed did not meet criteria for noninferiority to insulin on the outcome of the proportion of infants born large for gestational age, a multicenter trial of 820 patients in the Netherlands found.

U.K. consensus statement targets potential barriers to CGM use

Primary care teams face a critical need for education, training, and resources such as electronic health record integration to increase use of continuous glucose monitoring (CGM) in type 2 diabetes, an industry-funded consensus statement said.

MKSAP quiz: Treating CKD

This month's quiz asks readers to evaluate a 60-year-old woman with stage G3 proteinuric chronic kidney disease (CKD) due to type 2 diabetes mellitus.

Spotlight on interventions for the underserved

Project ECHO for diabetes lowered HbA1c levels in patients at federally qualified health centers, one study found, but another trial did not identify any improvements in glycemic control from providing patients on Medicaid with medically tailored meals.

Weekly efsitora compared to degludec in type 1 and type 2 diabetes by industry studies

Although two manufacturer trials showed that the weekly insulin efsitora was noninferior to daily degludec, that finding might not be sufficient to justify its use, particularly in patients with type 1 diabetes, an ACP Journal Club commentary said.

Recent FDA announcements affect diabetes care

Tirzepatide received a new indication, liraglutide got a generic version, and insulin syringes were recalled, in FDA news.